Download App

Log in to access Online Inquiry
Company Overview More
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients’ outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
CEO: Bousbib, Ari
Market: NYSE
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

IQV IQVIA Holdings
206.690+0.240+0.12%
Pre Mkt Price
207.100+0.41+0.20%
YOY
Do not show
Hide blank lines
(Q1)2022/03/31(FY)2021/12/31(Q4)2021/12/31(Q3)2021/09/30
Assets
Current assets
Cash, cash equivalents and short term investments
-37.84% 1.49B -22.34% 1.48B -22.34% 1.48B 2.01% 1.57B
-Cash and cash equivalents
-39.83% 1.39B -24.7% 1.37B -24.7% 1.37B 0.41% 1.47B
-Short-term investments
9.28% 106M 26.14% 111M 26.14% 111M 31.65% 104M
Receivables
9.77% 2.66B 5.8% 2.61B 5.8% 2.61B -4.25% 2.39B
-Accounts receivable
5.87% 1.23B 7.96% 1.28B 5.85% 2.55B -0.95% 1.14B
-Taxes receivable
-32.81% 43M 3.57% 58M 3.57% 58M -28.21% 56M
-Other receivables
15.33% 1.42B 3.64% 1.31B -- -- -5.65% 1.22B
-Recievables adjustments allowances
3.23% -30M 2.94% -33M -- -- 0% -30M
Prepaid assets
1.89% 162M -1.89% 156M -1.89% 156M -0.61% 164M
Other current assets
-23.27% 455M -7.46% 521M -7.46% 521M -7.87% 410M
Total current assets
-14.46% 4.77B -6.42% 4.76B -6.42% 4.76B -2.39% 4.53B
Non current assets
Net PPE
3.19% 938M -5.25% 903M -5.25% 903M -5.63% 889M
-Gross PPE
3.19% 938M 2.58% 1.67B -5.25% 903M -5.63% 889M
-Accumulated depreciation
-- -- -13.67% -765M -- -- -- --
Goodwill and other intangible assets
6.46% 18.45B 2.16% 18.24B 2.16% 18.24B 2% 17.94B
-Goodwill
9% 13.53B 5.11% 13.3B 5.11% 13.3B 6.16% 13.12B
-Other intangible assets
0.04% 4.92B -5.03% 4.94B -5.03% 4.94B -7.85% 4.81B
Investments and advances
0% 162M 1.23% 164M 1.23% 164M -3.07% 158M
Non current deferred assets
12.15% 120M 8.77% 124M 8.77% 124M -16% 105M
Non current prepaid assets
38.95% 528M 27.2% 491M 27.2% 491M 9.02% 411M
Total non current assets
6.93% 20.2B 2.32% 19.93B 2.32% 19.93B 1.6% 19.5B
Total assets
2.05% 24.97B 0.51% 24.69B 0.51% 24.69B 0.82% 24.03B
Liabilities
Current liabilities
Payables
-0.1% 2.95B -74% 758M 6.96% 3.12B 6.01% 2.72B
-accounts payable
-0.11% 2.82B -77.92% 621M 5.97% 2.98B 8.21% 2.66B
-Total tax payable
0% 135M 34.31% 137M 34.31% 137M -47.52% 53M
Current accrued expenses
-- -- -- 1.41B -- -- -- --
Current debt and capital lease obligation
-37.5% 90M -38.93% 91M -38.93% 91M -36.81% 91M
-Current debt
-37.5% 90M -38.93% 91M -38.93% 91M -36.81% 91M
Current deferred liabilities
24% 1.93B 45.77% 1.83B 45.77% 1.83B 53.7% 1.83B
Other current liabilities
-12.5% 189M -14.46% 207M -14.46% 207M -12.65% 214M
Current liabilities
5.94% 5.16B 14.98% 5.24B 14.98% 5.24B 17.11% 4.85B
Non current liabilities
Long term debt and capital lease obligation
3.36% 12.86B -3.2% 12.35B -3.2% 12.35B -1.41% 12.4B
-Long term debt
3.76% 12.55B -2.83% 12.03B -2.83% 12.03B -0.93% 12.08B
-Long term capital lease obligation
-10.66% 310M -15.63% 313M -15.63% 313M -16.54% 323M
Non current deferred liabilities
35.01% 455M 21.3% 410M 21.3% 410M -30.77% 297M
Other non current liabilities
-0.85% 581M 2.53% 649M 2.53% 649M 13.1% 656M
Total non current liabilities
3.97% 13.89B -2.33% 13.41B -2.33% 13.41B -1.72% 13.36B
Total liabilities
4.5% 19.05B 1.99% 18.65B 1.99% 18.65B 2.67% 18.2B
Shareholders'equity
Share capital
-2.92% 10.75B -2.87% 10.78B -2.87% 10.78B -2.92% 10.75B
-common stock
-2.92% 10.75B -2.87% 10.78B -2.87% 10.78B -2.92% 10.75B
Retained earnings
72.46% 2.57B 75.65% 2.24B 75.65% 2.24B 66.23% 1.93B
Less: Treasury stock
11.99% 6.98B 6.58% 6.57B 6.58% 6.57B 5.49% 6.4B
Gains losses not affecting retained earnings
-11.44% -419M -98.05% -406M -98.05% -406M -40.38% -445M
Total stockholders'equity
-0.57% 5.92B 0.68% 6.04B 0.68% 6.04B -0.29% 5.83B
Noncontrolling interests
-- -- -- 0 -- 0 -- 0
Total equity
-5.1% 5.92B -3.79% 6.04B -3.79% 6.04B -4.55% 5.83B
Currency Unit
USDUSDUSDUSD
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
--Unqualified Opinion----

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%